OGC
TMO icon

Oak Grove Capital’s Thermo Fisher Scientific TMO Stock Holding History

Oak Grove Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$791K Buy
1,172
+10
+0.9% +$5.94K 0.04% 81
2026
Q2 		$583K Sell
1,162
-82
-7% -$39.4K 0.03% 84
2026
Q1 		$611K Hold
1,244
– – 0.05% 66
2025
Q4 		$721K Sell
1,244
-200
-14% -$113K 0.09% 53
2025
Q3 		$700K Sell
1,444
-1,750
-55% -$815K 0.1% 50
2025
Q2 		$1.3M Sell
3,194
-8,885
-74% -$3.71M 0.21% 42
2025
Q1 		$6.01M Sell
12,079
-256
-2% -$139K 1.25% 18
2024
Q4 		$6.42M Sell
12,335
-4
-0% -$2.2K 0.96% 23
2024
Q3 		$7.63M Buy
12,339
+6
+0% +$3.55K 1.25% 17
2024
Q2 		$6.82M Sell
12,333
-300
-2% -$172K 1.24% 16
2024
Q1 		$7.34M Sell
12,633
-100
-0.8% -$56.1K 1.48% 17
2023
Q4 		$6.76M Buy
12,733
+1,000
+9% +$484K 1.8% 18
2023
Q3 		$5.94M Sell
11,733
-100
-0.8% -$53.3K 2.06% 17
2023
Q2 		$6.17M Buy
11,833
+1,360
+13% +$734K 2.11% 16
2023
Q1 		$6.04M Buy
10,473
+146
+1% +$82.3K 2.47% 14
2022
Q4 		$5.69M Sell
10,327
-1,525
-13% -$808K 2.86% 13
2022
Q3 		$6.01M Buy
11,852
+2,360
+25% +$1.32M 2.03% 15
2022
Q2 		$5.16M Sell
9,492
-620
-6% -$341K 1.68% 18
2022
Q1 		$5.97M Buy
10,112
+50
+0.5% +$28.7K 1.21% 24
2021
Q4 		$6.71M Sell
10,062
-193
-2% -$121K 1.17% 23
2021
Q3 		$5.86M Sell
10,255
-50
-0.5% -$27.4K 1.26% 23
2021
Q2 		$5.2M Buy
10,305
+550
+6% +$260K 1.16% 25
2021
Q1 		$4.45M Sell
9,755
-150
-2% -$71.6K 1.24% 29
2020
Q4 		$4.61M Buy
9,905
+3,015
+44% +$1.41M 1.51% 26
2020
Q3 		$3.04M Sell
6,890
-90
-1% -$37.2K 1.44% 25
2020
Q2 		$2.53M Buy
+6,980
New +$2.34M 1.52% 20

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Oak Grove Capital's TMO Position: Q3 2026 in Review

Oak Grove Capital increased its Thermo Fisher Scientific (TMO) stake by 0.86% in Q3 2026, buying an estimated $5.94K and bringing the position to 1,172 shares worth $791K. The position accounts for 0.04% of the portfolio, ranked #81.

Oak Grove Capital first reported a position in TMO in Q2 2020 and has held it in 26 quarters since. The position peaked at $7.63M in Q3 2024. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Oak Grove Capital held 1,172 shares of Thermo Fisher Scientific worth $791K as of Q3 2026.
  • Oak Grove Capital bought 10 Thermo Fisher Scientific shares in Q3 2026, an estimated $5.94K.
  • Thermo Fisher Scientific made up 0.04% of Oak Grove Capital's portfolio in Q3 2026, its #81 holding.
  • Oak Grove Capital first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 26 quarters since.
  • Oak Grove Capital's Thermo Fisher Scientific position peaked at $7.63M in Q3 2024.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Oak Grove Capital's 13F filing for Q3 2026, filed 9 Oct 2026.